Global Antiviral Drugs for Influenza Market Research Report 2026(Status and Outlook)
Antiviral drugs for influenza are medications specifically designed to inhibit the replication of influenza viruses within the body. These drugs help reduce the severity and duration of flu symptoms, lower the risk of complications, and, in some cases, prevent infection. Antiviral drugs for influenza are classified into different categories based on their mechanisms of action, including neuraminidase inhibitors (e.g., oseltamivir, zanamivir, peramivir), polymerase inhibitors (e.g., baloxavir marboxil), and M2 proton channel inhibitors (e.g., amantadine, rimantadine, though these are rarely used due to resistance). They are most effective when taken within 48 hours of symptom onset and are typically available by prescription.
The global Antiviral Drugs for Influenza market size was estimated at USD 96.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antiviral Drugs for Influenza market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antiviral Drugs for Influenza market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiviral Drugs for Influenza market.
Global Antiviral Drugs for Influenza Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioCryst Pharmaceuticals
AdvaCare Pharma
Roche
GlaxoSmithKline
Morningside Pharmaceuticals
Avexima
Teva Pharmaceuticals
Daiichi Sankyo
Shionogi
Wockhardt
Market Segmentation (by Type)
Neuraminidase Inhibitors
Polymerase Inhibitors
Market Segmentation (by Application)
Over-the-counter (OTC)
Prescription (Rx)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiviral Drugs for Influenza Market
Overview of the regional outlook of the Antiviral Drugs for Influenza Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiviral Drugs for Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiviral Drugs for Influenza, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Antiviral Drugs for Influenza market size was estimated at USD 96.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antiviral Drugs for Influenza market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antiviral Drugs for Influenza market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antiviral Drugs for Influenza market.
Global Antiviral Drugs for Influenza Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioCryst Pharmaceuticals
AdvaCare Pharma
Roche
GlaxoSmithKline
Morningside Pharmaceuticals
Avexima
Teva Pharmaceuticals
Daiichi Sankyo
Shionogi
Wockhardt
Market Segmentation (by Type)
Neuraminidase Inhibitors
Polymerase Inhibitors
Market Segmentation (by Application)
Over-the-counter (OTC)
Prescription (Rx)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Antiviral Drugs for Influenza Market
Overview of the regional outlook of the Antiviral Drugs for Influenza Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiviral Drugs for Influenza Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antiviral Drugs for Influenza, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antiviral Drugs for Influenza
1.2 Key Market Segments
1.2.1 Antiviral Drugs for Influenza Segment by Type
1.2.2 Antiviral Drugs for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIVIRAL DRUGS FOR INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiviral Drugs for Influenza Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Antiviral Drugs for Influenza Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIVIRAL DRUGS FOR INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antiviral Drugs for Influenza Product Life Cycle
3.3 Global Antiviral Drugs for Influenza Sales by Manufacturers (2020-2025)
3.4 Global Antiviral Drugs for Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Antiviral Drugs for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antiviral Drugs for Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antiviral Drugs for Influenza Market Competitive Situation and Trends
3.8.1 Antiviral Drugs for Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antiviral Drugs for Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIVIRAL DRUGS FOR INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Antiviral Drugs for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRAL DRUGS FOR INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antiviral Drugs for Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antiviral Drugs for Influenza Market
5.7 ESG Ratings of Leading Companies
6 ANTIVIRAL DRUGS FOR INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiviral Drugs for Influenza Sales Market Share by Type (2020-2025)
6.3 Global Antiviral Drugs for Influenza Market Size by Type (2020-2025)
6.4 Global Antiviral Drugs for Influenza Price by Type (2020-2025)
7 ANTIVIRAL DRUGS FOR INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiviral Drugs for Influenza Market Sales by Application (2020-2025)
7.3 Global Antiviral Drugs for Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Antiviral Drugs for Influenza Sales Growth Rate by Application (2020-2025)
8 ANTIVIRAL DRUGS FOR INFLUENZA MARKET SALES BY REGION
8.1 Global Antiviral Drugs for Influenza Sales by Region
8.1.1 Global Antiviral Drugs for Influenza Sales by Region
8.1.2 Global Antiviral Drugs for Influenza Sales Market Share by Region
8.2 Global Antiviral Drugs for Influenza Market Size by Region
8.2.1 Global Antiviral Drugs for Influenza Market Size by Region
8.2.2 Global Antiviral Drugs for Influenza Market Size by Region
8.3 North America
8.3.1 North America Antiviral Drugs for Influenza Sales by Country
8.3.2 North America Antiviral Drugs for Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antiviral Drugs for Influenza Sales by Country
8.4.2 Europe Antiviral Drugs for Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antiviral Drugs for Influenza Sales by Region
8.5.2 Asia Pacific Antiviral Drugs for Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antiviral Drugs for Influenza Sales by Country
8.6.2 South America Antiviral Drugs for Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antiviral Drugs for Influenza Sales by Region
8.7.2 Middle East and Africa Antiviral Drugs for Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIVIRAL DRUGS FOR INFLUENZA MARKET PRODUCTION BY REGION
9.1 Global Production of Antiviral Drugs for Influenza by Region(2020-2025)
9.2 Global Antiviral Drugs for Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antiviral Drugs for Influenza Production
9.4.1 North America Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.4.2 North America Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antiviral Drugs for Influenza Production
9.5.1 Europe Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antiviral Drugs for Influenza Production (2020-2025)
9.6.1 Japan Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antiviral Drugs for Influenza Production (2020-2025)
9.7.1 China Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.7.2 China Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BioCryst Pharmaceuticals
10.1.1 BioCryst Pharmaceuticals Basic Information
10.1.2 BioCryst Pharmaceuticals Antiviral Drugs for Influenza Product Overview
10.1.3 BioCryst Pharmaceuticals Antiviral Drugs for Influenza Product Market Performance
10.1.4 BioCryst Pharmaceuticals Business Overview
10.1.5 BioCryst Pharmaceuticals SWOT Analysis
10.1.6 BioCryst Pharmaceuticals Recent Developments
10.2 AdvaCare Pharma
10.2.1 AdvaCare Pharma Basic Information
10.2.2 AdvaCare Pharma Antiviral Drugs for Influenza Product Overview
10.2.3 AdvaCare Pharma Antiviral Drugs for Influenza Product Market Performance
10.2.4 AdvaCare Pharma Business Overview
10.2.5 AdvaCare Pharma SWOT Analysis
10.2.6 AdvaCare Pharma Recent Developments
10.3 Roche
10.3.1 Roche Basic Information
10.3.2 Roche Antiviral Drugs for Influenza Product Overview
10.3.3 Roche Antiviral Drugs for Influenza Product Market Performance
10.3.4 Roche Business Overview
10.3.5 Roche SWOT Analysis
10.3.6 Roche Recent Developments
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Basic Information
10.4.2 GlaxoSmithKline Antiviral Drugs for Influenza Product Overview
10.4.3 GlaxoSmithKline Antiviral Drugs for Influenza Product Market Performance
10.4.4 GlaxoSmithKline Business Overview
10.4.5 GlaxoSmithKline Recent Developments
10.5 Morningside Pharmaceuticals
10.5.1 Morningside Pharmaceuticals Basic Information
10.5.2 Morningside Pharmaceuticals Antiviral Drugs for Influenza Product Overview
10.5.3 Morningside Pharmaceuticals Antiviral Drugs for Influenza Product Market Performance
10.5.4 Morningside Pharmaceuticals Business Overview
10.5.5 Morningside Pharmaceuticals Recent Developments
10.6 Avexima
10.6.1 Avexima Basic Information
10.6.2 Avexima Antiviral Drugs for Influenza Product Overview
10.6.3 Avexima Antiviral Drugs for Influenza Product Market Performance
10.6.4 Avexima Business Overview
10.6.5 Avexima Recent Developments
10.7 Teva Pharmaceuticals
10.7.1 Teva Pharmaceuticals Basic Information
10.7.2 Teva Pharmaceuticals Antiviral Drugs for Influenza Product Overview
10.7.3 Teva Pharmaceuticals Antiviral Drugs for Influenza Product Market Performance
10.7.4 Teva Pharmaceuticals Business Overview
10.7.5 Teva Pharmaceuticals Recent Developments
10.8 Daiichi Sankyo
10.8.1 Daiichi Sankyo Basic Information
10.8.2 Daiichi Sankyo Antiviral Drugs for Influenza Product Overview
10.8.3 Daiichi Sankyo Antiviral Drugs for Influenza Product Market Performance
10.8.4 Daiichi Sankyo Business Overview
10.8.5 Daiichi Sankyo Recent Developments
10.9 Shionogi
10.9.1 Shionogi Basic Information
10.9.2 Shionogi Antiviral Drugs for Influenza Product Overview
10.9.3 Shionogi Antiviral Drugs for Influenza Product Market Performance
10.9.4 Shionogi Business Overview
10.9.5 Shionogi Recent Developments
10.10 Wockhardt
10.10.1 Wockhardt Basic Information
10.10.2 Wockhardt Antiviral Drugs for Influenza Product Overview
10.10.3 Wockhardt Antiviral Drugs for Influenza Product Market Performance
10.10.4 Wockhardt Business Overview
10.10.5 Wockhardt Recent Developments
11 ANTIVIRAL DRUGS FOR INFLUENZA MARKET FORECAST BY REGION
11.1 Global Antiviral Drugs for Influenza Market Size Forecast
11.2 Global Antiviral Drugs for Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antiviral Drugs for Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Antiviral Drugs for Influenza Market Size Forecast by Region
11.2.4 South America Antiviral Drugs for Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antiviral Drugs for Influenza by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Antiviral Drugs for Influenza Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Antiviral Drugs for Influenza by Type (2026-2035)
12.1.2 Global Antiviral Drugs for Influenza Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Antiviral Drugs for Influenza by Type (2026-2035)
12.2 Global Antiviral Drugs for Influenza Market Forecast by Application (2026-2035)
12.2.1 Global Antiviral Drugs for Influenza Sales (K MT) Forecast by Application
12.2.2 Global Antiviral Drugs for Influenza Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antiviral Drugs for Influenza
1.2 Key Market Segments
1.2.1 Antiviral Drugs for Influenza Segment by Type
1.2.2 Antiviral Drugs for Influenza Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIVIRAL DRUGS FOR INFLUENZA MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiviral Drugs for Influenza Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Antiviral Drugs for Influenza Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIVIRAL DRUGS FOR INFLUENZA MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antiviral Drugs for Influenza Product Life Cycle
3.3 Global Antiviral Drugs for Influenza Sales by Manufacturers (2020-2025)
3.4 Global Antiviral Drugs for Influenza Revenue Market Share by Manufacturers (2020-2025)
3.5 Antiviral Drugs for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antiviral Drugs for Influenza Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antiviral Drugs for Influenza Market Competitive Situation and Trends
3.8.1 Antiviral Drugs for Influenza Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antiviral Drugs for Influenza Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIVIRAL DRUGS FOR INFLUENZA INDUSTRY CHAIN ANALYSIS
4.1 Antiviral Drugs for Influenza Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRAL DRUGS FOR INFLUENZA MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antiviral Drugs for Influenza Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antiviral Drugs for Influenza Market
5.7 ESG Ratings of Leading Companies
6 ANTIVIRAL DRUGS FOR INFLUENZA MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiviral Drugs for Influenza Sales Market Share by Type (2020-2025)
6.3 Global Antiviral Drugs for Influenza Market Size by Type (2020-2025)
6.4 Global Antiviral Drugs for Influenza Price by Type (2020-2025)
7 ANTIVIRAL DRUGS FOR INFLUENZA MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiviral Drugs for Influenza Market Sales by Application (2020-2025)
7.3 Global Antiviral Drugs for Influenza Market Size (M USD) by Application (2020-2025)
7.4 Global Antiviral Drugs for Influenza Sales Growth Rate by Application (2020-2025)
8 ANTIVIRAL DRUGS FOR INFLUENZA MARKET SALES BY REGION
8.1 Global Antiviral Drugs for Influenza Sales by Region
8.1.1 Global Antiviral Drugs for Influenza Sales by Region
8.1.2 Global Antiviral Drugs for Influenza Sales Market Share by Region
8.2 Global Antiviral Drugs for Influenza Market Size by Region
8.2.1 Global Antiviral Drugs for Influenza Market Size by Region
8.2.2 Global Antiviral Drugs for Influenza Market Size by Region
8.3 North America
8.3.1 North America Antiviral Drugs for Influenza Sales by Country
8.3.2 North America Antiviral Drugs for Influenza Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antiviral Drugs for Influenza Sales by Country
8.4.2 Europe Antiviral Drugs for Influenza Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antiviral Drugs for Influenza Sales by Region
8.5.2 Asia Pacific Antiviral Drugs for Influenza Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antiviral Drugs for Influenza Sales by Country
8.6.2 South America Antiviral Drugs for Influenza Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antiviral Drugs for Influenza Sales by Region
8.7.2 Middle East and Africa Antiviral Drugs for Influenza Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIVIRAL DRUGS FOR INFLUENZA MARKET PRODUCTION BY REGION
9.1 Global Production of Antiviral Drugs for Influenza by Region(2020-2025)
9.2 Global Antiviral Drugs for Influenza Revenue Market Share by Region (2020-2025)
9.3 Global Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antiviral Drugs for Influenza Production
9.4.1 North America Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.4.2 North America Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antiviral Drugs for Influenza Production
9.5.1 Europe Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.5.2 Europe Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antiviral Drugs for Influenza Production (2020-2025)
9.6.1 Japan Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.6.2 Japan Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antiviral Drugs for Influenza Production (2020-2025)
9.7.1 China Antiviral Drugs for Influenza Production Growth Rate (2020-2025)
9.7.2 China Antiviral Drugs for Influenza Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BioCryst Pharmaceuticals
10.1.1 BioCryst Pharmaceuticals Basic Information
10.1.2 BioCryst Pharmaceuticals Antiviral Drugs for Influenza Product Overview
10.1.3 BioCryst Pharmaceuticals Antiviral Drugs for Influenza Product Market Performance
10.1.4 BioCryst Pharmaceuticals Business Overview
10.1.5 BioCryst Pharmaceuticals SWOT Analysis
10.1.6 BioCryst Pharmaceuticals Recent Developments
10.2 AdvaCare Pharma
10.2.1 AdvaCare Pharma Basic Information
10.2.2 AdvaCare Pharma Antiviral Drugs for Influenza Product Overview
10.2.3 AdvaCare Pharma Antiviral Drugs for Influenza Product Market Performance
10.2.4 AdvaCare Pharma Business Overview
10.2.5 AdvaCare Pharma SWOT Analysis
10.2.6 AdvaCare Pharma Recent Developments
10.3 Roche
10.3.1 Roche Basic Information
10.3.2 Roche Antiviral Drugs for Influenza Product Overview
10.3.3 Roche Antiviral Drugs for Influenza Product Market Performance
10.3.4 Roche Business Overview
10.3.5 Roche SWOT Analysis
10.3.6 Roche Recent Developments
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Basic Information
10.4.2 GlaxoSmithKline Antiviral Drugs for Influenza Product Overview
10.4.3 GlaxoSmithKline Antiviral Drugs for Influenza Product Market Performance
10.4.4 GlaxoSmithKline Business Overview
10.4.5 GlaxoSmithKline Recent Developments
10.5 Morningside Pharmaceuticals
10.5.1 Morningside Pharmaceuticals Basic Information
10.5.2 Morningside Pharmaceuticals Antiviral Drugs for Influenza Product Overview
10.5.3 Morningside Pharmaceuticals Antiviral Drugs for Influenza Product Market Performance
10.5.4 Morningside Pharmaceuticals Business Overview
10.5.5 Morningside Pharmaceuticals Recent Developments
10.6 Avexima
10.6.1 Avexima Basic Information
10.6.2 Avexima Antiviral Drugs for Influenza Product Overview
10.6.3 Avexima Antiviral Drugs for Influenza Product Market Performance
10.6.4 Avexima Business Overview
10.6.5 Avexima Recent Developments
10.7 Teva Pharmaceuticals
10.7.1 Teva Pharmaceuticals Basic Information
10.7.2 Teva Pharmaceuticals Antiviral Drugs for Influenza Product Overview
10.7.3 Teva Pharmaceuticals Antiviral Drugs for Influenza Product Market Performance
10.7.4 Teva Pharmaceuticals Business Overview
10.7.5 Teva Pharmaceuticals Recent Developments
10.8 Daiichi Sankyo
10.8.1 Daiichi Sankyo Basic Information
10.8.2 Daiichi Sankyo Antiviral Drugs for Influenza Product Overview
10.8.3 Daiichi Sankyo Antiviral Drugs for Influenza Product Market Performance
10.8.4 Daiichi Sankyo Business Overview
10.8.5 Daiichi Sankyo Recent Developments
10.9 Shionogi
10.9.1 Shionogi Basic Information
10.9.2 Shionogi Antiviral Drugs for Influenza Product Overview
10.9.3 Shionogi Antiviral Drugs for Influenza Product Market Performance
10.9.4 Shionogi Business Overview
10.9.5 Shionogi Recent Developments
10.10 Wockhardt
10.10.1 Wockhardt Basic Information
10.10.2 Wockhardt Antiviral Drugs for Influenza Product Overview
10.10.3 Wockhardt Antiviral Drugs for Influenza Product Market Performance
10.10.4 Wockhardt Business Overview
10.10.5 Wockhardt Recent Developments
11 ANTIVIRAL DRUGS FOR INFLUENZA MARKET FORECAST BY REGION
11.1 Global Antiviral Drugs for Influenza Market Size Forecast
11.2 Global Antiviral Drugs for Influenza Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antiviral Drugs for Influenza Market Size Forecast by Country
11.2.3 Asia Pacific Antiviral Drugs for Influenza Market Size Forecast by Region
11.2.4 South America Antiviral Drugs for Influenza Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antiviral Drugs for Influenza by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Antiviral Drugs for Influenza Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Antiviral Drugs for Influenza by Type (2026-2035)
12.1.2 Global Antiviral Drugs for Influenza Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Antiviral Drugs for Influenza by Type (2026-2035)
12.2 Global Antiviral Drugs for Influenza Market Forecast by Application (2026-2035)
12.2.1 Global Antiviral Drugs for Influenza Sales (K MT) Forecast by Application
12.2.2 Global Antiviral Drugs for Influenza Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antiviral Drugs for Influenza Market Size by Type (M USD)
Table 4. Global Antiviral Drugs for Influenza Market Size by Application
Table 5. Antiviral Drugs for Influenza Market Size Comparison by Region (M USD)
Table 6. Global Antiviral Drugs for Influenza Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antiviral Drugs for Influenza Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antiviral Drugs for Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antiviral Drugs for Influenza Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drugs for Influenza as of 2025)
Table 11. Global Market Antiviral Drugs for Influenza Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Antiviral Drugs for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiviral Drugs for Influenza Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antiviral Drugs for Influenza Sales by Type (K MT)
Table 27. Global Antiviral Drugs for Influenza Market Size by Type (M USD)
Table 28. Global Antiviral Drugs for Influenza Sales (K MT) by Type (2020-2025)
Table 29. Global Antiviral Drugs for Influenza Sales Market Share by Type (2020-2025)
Table 30. Global Antiviral Drugs for Influenza Market Size (M USD) by Type (2020-2025)
Table 31. Global Antiviral Drugs for Influenza Market Share by Type (2020-2025)
Table 32. Global Antiviral Drugs for Influenza Price (USD/KG) by Type (2020-2025)
Table 33. Global Antiviral Drugs for Influenza Sales (K MT) by Application
Table 34. Global Antiviral Drugs for Influenza Market Size by Application
Table 35. Global Antiviral Drugs for Influenza Sales by Application (2020-2025) & (K MT)
Table 36. Global Antiviral Drugs for Influenza Sales Market Share by Application (2020-2025)
Table 37. Global Antiviral Drugs for Influenza Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antiviral Drugs for Influenza Market Share by Application (2020-2025)
Table 39. Global Antiviral Drugs for Influenza Sales Growth Rate by Application (2020-2025)
Table 40. Global Antiviral Drugs for Influenza Sales by Region (2020-2025) & (K MT)
Table 41. Global Antiviral Drugs for Influenza Sales Market Share by Region (2020-2025)
Table 42. Global Antiviral Drugs for Influenza Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antiviral Drugs for Influenza Market Size by Region (2020-2025)
Table 44. North America Antiviral Drugs for Influenza Sales by Country (2020-2025) & (K MT)
Table 45. North America Antiviral Drugs for Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antiviral Drugs for Influenza Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antiviral Drugs for Influenza Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antiviral Drugs for Influenza Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antiviral Drugs for Influenza Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antiviral Drugs for Influenza Sales by Country (2020-2025) & (K MT)
Table 51. South America Antiviral Drugs for Influenza Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antiviral Drugs for Influenza Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antiviral Drugs for Influenza Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antiviral Drugs for Influenza Production (K MT) by Region(2020-2025)
Table 55. Global Antiviral Drugs for Influenza Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antiviral Drugs for Influenza Revenue Market Share by Region (2020-2025)
Table 57. Global Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. BioCryst Pharmaceuticals Basic Information
Table 63. BioCryst Pharmaceuticals Antiviral Drugs for Influenza Product Overview
Table 64. BioCryst Pharmaceuticals Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. BioCryst Pharmaceuticals Business Overview
Table 66. BioCryst Pharmaceuticals SWOT Analysis
Table 67. BioCryst Pharmaceuticals Recent Developments
Table 68. AdvaCare Pharma Basic Information
Table 69. AdvaCare Pharma Antiviral Drugs for Influenza Product Overview
Table 70. AdvaCare Pharma Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AdvaCare Pharma Business Overview
Table 72. AdvaCare Pharma SWOT Analysis
Table 73. AdvaCare Pharma Recent Developments
Table 74. Roche Basic Information
Table 75. Roche Antiviral Drugs for Influenza Product Overview
Table 76. Roche Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Roche Business Overview
Table 78. Roche SWOT Analysis
Table 79. Roche Recent Developments
Table 80. GlaxoSmithKline Basic Information
Table 81. GlaxoSmithKline Antiviral Drugs for Influenza Product Overview
Table 82. GlaxoSmithKline Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Recent Developments
Table 85. Morningside Pharmaceuticals Basic Information
Table 86. Morningside Pharmaceuticals Antiviral Drugs for Influenza Product Overview
Table 87. Morningside Pharmaceuticals Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Morningside Pharmaceuticals Business Overview
Table 89. Morningside Pharmaceuticals Recent Developments
Table 90. Avexima Basic Information
Table 91. Avexima Antiviral Drugs for Influenza Product Overview
Table 92. Avexima Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Avexima Business Overview
Table 94. Avexima Recent Developments
Table 95. Teva Pharmaceuticals Basic Information
Table 96. Teva Pharmaceuticals Antiviral Drugs for Influenza Product Overview
Table 97. Teva Pharmaceuticals Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceuticals Business Overview
Table 99. Teva Pharmaceuticals Recent Developments
Table 100. Daiichi Sankyo Basic Information
Table 101. Daiichi Sankyo Antiviral Drugs for Influenza Product Overview
Table 102. Daiichi Sankyo Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Daiichi Sankyo Business Overview
Table 104. Daiichi Sankyo Recent Developments
Table 105. Shionogi Basic Information
Table 106. Shionogi Antiviral Drugs for Influenza Product Overview
Table 107. Shionogi Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Shionogi Business Overview
Table 109. Shionogi Recent Developments
Table 110. Wockhardt Basic Information
Table 111. Wockhardt Antiviral Drugs for Influenza Product Overview
Table 112. Wockhardt Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Wockhardt Business Overview
Table 114. Wockhardt Recent Developments
Table 115. Global Antiviral Drugs for Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Antiviral Drugs for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Antiviral Drugs for Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Antiviral Drugs for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Antiviral Drugs for Influenza Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Antiviral Drugs for Influenza Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Antiviral Drugs for Influenza Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Antiviral Drugs for Influenza Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Antiviral Drugs for Influenza Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Antiviral Drugs for Influenza Market Size by Type (M USD)
Table 4. Global Antiviral Drugs for Influenza Market Size by Application
Table 5. Antiviral Drugs for Influenza Market Size Comparison by Region (M USD)
Table 6. Global Antiviral Drugs for Influenza Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Antiviral Drugs for Influenza Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Antiviral Drugs for Influenza Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Antiviral Drugs for Influenza Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drugs for Influenza as of 2025)
Table 11. Global Market Antiviral Drugs for Influenza Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Antiviral Drugs for Influenza Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiviral Drugs for Influenza Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Antiviral Drugs for Influenza Sales by Type (K MT)
Table 27. Global Antiviral Drugs for Influenza Market Size by Type (M USD)
Table 28. Global Antiviral Drugs for Influenza Sales (K MT) by Type (2020-2025)
Table 29. Global Antiviral Drugs for Influenza Sales Market Share by Type (2020-2025)
Table 30. Global Antiviral Drugs for Influenza Market Size (M USD) by Type (2020-2025)
Table 31. Global Antiviral Drugs for Influenza Market Share by Type (2020-2025)
Table 32. Global Antiviral Drugs for Influenza Price (USD/KG) by Type (2020-2025)
Table 33. Global Antiviral Drugs for Influenza Sales (K MT) by Application
Table 34. Global Antiviral Drugs for Influenza Market Size by Application
Table 35. Global Antiviral Drugs for Influenza Sales by Application (2020-2025) & (K MT)
Table 36. Global Antiviral Drugs for Influenza Sales Market Share by Application (2020-2025)
Table 37. Global Antiviral Drugs for Influenza Market Size by Application (2020-2025) & (M USD)
Table 38. Global Antiviral Drugs for Influenza Market Share by Application (2020-2025)
Table 39. Global Antiviral Drugs for Influenza Sales Growth Rate by Application (2020-2025)
Table 40. Global Antiviral Drugs for Influenza Sales by Region (2020-2025) & (K MT)
Table 41. Global Antiviral Drugs for Influenza Sales Market Share by Region (2020-2025)
Table 42. Global Antiviral Drugs for Influenza Market Size by Region (2020-2025) & (M USD)
Table 43. Global Antiviral Drugs for Influenza Market Size by Region (2020-2025)
Table 44. North America Antiviral Drugs for Influenza Sales by Country (2020-2025) & (K MT)
Table 45. North America Antiviral Drugs for Influenza Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Antiviral Drugs for Influenza Sales by Country (2020-2025) & (K MT)
Table 47. Europe Antiviral Drugs for Influenza Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Antiviral Drugs for Influenza Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Antiviral Drugs for Influenza Market Size by Region (2020-2025) & (M USD)
Table 50. South America Antiviral Drugs for Influenza Sales by Country (2020-2025) & (K MT)
Table 51. South America Antiviral Drugs for Influenza Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Antiviral Drugs for Influenza Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Antiviral Drugs for Influenza Market Size by Region (2020-2025) & (M USD)
Table 54. Global Antiviral Drugs for Influenza Production (K MT) by Region(2020-2025)
Table 55. Global Antiviral Drugs for Influenza Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Antiviral Drugs for Influenza Revenue Market Share by Region (2020-2025)
Table 57. Global Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Antiviral Drugs for Influenza Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. BioCryst Pharmaceuticals Basic Information
Table 63. BioCryst Pharmaceuticals Antiviral Drugs for Influenza Product Overview
Table 64. BioCryst Pharmaceuticals Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. BioCryst Pharmaceuticals Business Overview
Table 66. BioCryst Pharmaceuticals SWOT Analysis
Table 67. BioCryst Pharmaceuticals Recent Developments
Table 68. AdvaCare Pharma Basic Information
Table 69. AdvaCare Pharma Antiviral Drugs for Influenza Product Overview
Table 70. AdvaCare Pharma Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AdvaCare Pharma Business Overview
Table 72. AdvaCare Pharma SWOT Analysis
Table 73. AdvaCare Pharma Recent Developments
Table 74. Roche Basic Information
Table 75. Roche Antiviral Drugs for Influenza Product Overview
Table 76. Roche Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Roche Business Overview
Table 78. Roche SWOT Analysis
Table 79. Roche Recent Developments
Table 80. GlaxoSmithKline Basic Information
Table 81. GlaxoSmithKline Antiviral Drugs for Influenza Product Overview
Table 82. GlaxoSmithKline Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Recent Developments
Table 85. Morningside Pharmaceuticals Basic Information
Table 86. Morningside Pharmaceuticals Antiviral Drugs for Influenza Product Overview
Table 87. Morningside Pharmaceuticals Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Morningside Pharmaceuticals Business Overview
Table 89. Morningside Pharmaceuticals Recent Developments
Table 90. Avexima Basic Information
Table 91. Avexima Antiviral Drugs for Influenza Product Overview
Table 92. Avexima Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Avexima Business Overview
Table 94. Avexima Recent Developments
Table 95. Teva Pharmaceuticals Basic Information
Table 96. Teva Pharmaceuticals Antiviral Drugs for Influenza Product Overview
Table 97. Teva Pharmaceuticals Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Teva Pharmaceuticals Business Overview
Table 99. Teva Pharmaceuticals Recent Developments
Table 100. Daiichi Sankyo Basic Information
Table 101. Daiichi Sankyo Antiviral Drugs for Influenza Product Overview
Table 102. Daiichi Sankyo Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Daiichi Sankyo Business Overview
Table 104. Daiichi Sankyo Recent Developments
Table 105. Shionogi Basic Information
Table 106. Shionogi Antiviral Drugs for Influenza Product Overview
Table 107. Shionogi Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Shionogi Business Overview
Table 109. Shionogi Recent Developments
Table 110. Wockhardt Basic Information
Table 111. Wockhardt Antiviral Drugs for Influenza Product Overview
Table 112. Wockhardt Antiviral Drugs for Influenza Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Wockhardt Business Overview
Table 114. Wockhardt Recent Developments
Table 115. Global Antiviral Drugs for Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Antiviral Drugs for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Antiviral Drugs for Influenza Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Antiviral Drugs for Influenza Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Antiviral Drugs for Influenza Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Antiviral Drugs for Influenza Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Antiviral Drugs for Influenza Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Antiviral Drugs for Influenza Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Antiviral Drugs for Influenza Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Antiviral Drugs for Influenza Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Antiviral Drugs for Influenza Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antiviral Drugs for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiviral Drugs for Influenza Market Size (M USD), 2025-2035
Figure 5. Global Antiviral Drugs for Influenza Market Size (M USD) (2020-2035)
Figure 6. Global Antiviral Drugs for Influenza Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiviral Drugs for Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antiviral Drugs for Influenza Product Life Cycle
Figure 13. Antiviral Drugs for Influenza Sales Share by Manufacturers in 2025
Figure 14. Global Antiviral Drugs for Influenza Revenue Share by Manufacturers in 2025
Figure 15. Antiviral Drugs for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antiviral Drugs for Influenza Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antiviral Drugs for Influenza Revenue in 2025
Figure 18. Industry Chain Map of Antiviral Drugs for Influenza
Figure 19. Global Antiviral Drugs for Influenza Market PEST Analysis
Figure 20. Global Antiviral Drugs for Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antiviral Drugs for Influenza Market Share by Type
Figure 27. Sales Market Share of Antiviral Drugs for Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Antiviral Drugs for Influenza by Type in 2025
Figure 29. Market Share of Antiviral Drugs for Influenza by Type (2020-2025)
Figure 30. Market Share of Antiviral Drugs for Influenza by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antiviral Drugs for Influenza Market Share by Application
Figure 33. Global Antiviral Drugs for Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Antiviral Drugs for Influenza Sales Market Share by Application in 2025
Figure 35. Global Antiviral Drugs for Influenza Market Share by Application (2020-2025)
Figure 36. Global Antiviral Drugs for Influenza Market Share by Application in 2025
Figure 37. Global Antiviral Drugs for Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antiviral Drugs for Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Antiviral Drugs for Influenza Market Size by Region (2020-2025)
Figure 40. North America Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antiviral Drugs for Influenza Sales Market Share by Country in 2024
Figure 43. North America Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antiviral Drugs for Influenza Market Size by Country in 2024
Figure 45. U.S. Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antiviral Drugs for Influenza Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antiviral Drugs for Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antiviral Drugs for Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antiviral Drugs for Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antiviral Drugs for Influenza Sales Market Share by Country in 2024
Figure 53. Europe Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antiviral Drugs for Influenza Market Size by Country in 2024
Figure 55. Germany Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antiviral Drugs for Influenza Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antiviral Drugs for Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antiviral Drugs for Influenza Market Size by Region in 2024
Figure 68. China Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antiviral Drugs for Influenza Sales and Growth Rate (K MT)
Figure 79. South America Antiviral Drugs for Influenza Sales Market Share by Country in 2024
Figure 80. South America Antiviral Drugs for Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Antiviral Drugs for Influenza Market Size by Country in 2024
Figure 82. Brazil Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antiviral Drugs for Influenza Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antiviral Drugs for Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antiviral Drugs for Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antiviral Drugs for Influenza Market Size by Region in 2024
Figure 92. Saudi Arabia Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antiviral Drugs for Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antiviral Drugs for Influenza Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antiviral Drugs for Influenza Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antiviral Drugs for Influenza Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antiviral Drugs for Influenza Market Share Forecast by Type (2026-2035)
Figure 111. Global Antiviral Drugs for Influenza Sales Forecast by Application (2026-2035)
Figure 112. Global Antiviral Drugs for Influenza Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Antiviral Drugs for Influenza
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiviral Drugs for Influenza Market Size (M USD), 2025-2035
Figure 5. Global Antiviral Drugs for Influenza Market Size (M USD) (2020-2035)
Figure 6. Global Antiviral Drugs for Influenza Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiviral Drugs for Influenza Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antiviral Drugs for Influenza Product Life Cycle
Figure 13. Antiviral Drugs for Influenza Sales Share by Manufacturers in 2025
Figure 14. Global Antiviral Drugs for Influenza Revenue Share by Manufacturers in 2025
Figure 15. Antiviral Drugs for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Antiviral Drugs for Influenza Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antiviral Drugs for Influenza Revenue in 2025
Figure 18. Industry Chain Map of Antiviral Drugs for Influenza
Figure 19. Global Antiviral Drugs for Influenza Market PEST Analysis
Figure 20. Global Antiviral Drugs for Influenza Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antiviral Drugs for Influenza Market Share by Type
Figure 27. Sales Market Share of Antiviral Drugs for Influenza by Type (2020-2025)
Figure 28. Sales Market Share of Antiviral Drugs for Influenza by Type in 2025
Figure 29. Market Share of Antiviral Drugs for Influenza by Type (2020-2025)
Figure 30. Market Share of Antiviral Drugs for Influenza by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antiviral Drugs for Influenza Market Share by Application
Figure 33. Global Antiviral Drugs for Influenza Sales Market Share by Application (2020-2025)
Figure 34. Global Antiviral Drugs for Influenza Sales Market Share by Application in 2025
Figure 35. Global Antiviral Drugs for Influenza Market Share by Application (2020-2025)
Figure 36. Global Antiviral Drugs for Influenza Market Share by Application in 2025
Figure 37. Global Antiviral Drugs for Influenza Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antiviral Drugs for Influenza Sales Market Share by Region (2020-2025)
Figure 39. Global Antiviral Drugs for Influenza Market Size by Region (2020-2025)
Figure 40. North America Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antiviral Drugs for Influenza Sales Market Share by Country in 2024
Figure 43. North America Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antiviral Drugs for Influenza Market Size by Country in 2024
Figure 45. U.S. Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antiviral Drugs for Influenza Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antiviral Drugs for Influenza Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antiviral Drugs for Influenza Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antiviral Drugs for Influenza Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antiviral Drugs for Influenza Sales Market Share by Country in 2024
Figure 53. Europe Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antiviral Drugs for Influenza Market Size by Country in 2024
Figure 55. Germany Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antiviral Drugs for Influenza Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antiviral Drugs for Influenza Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antiviral Drugs for Influenza Market Size by Region in 2024
Figure 68. China Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antiviral Drugs for Influenza Sales and Growth Rate (K MT)
Figure 79. South America Antiviral Drugs for Influenza Sales Market Share by Country in 2024
Figure 80. South America Antiviral Drugs for Influenza Market Size and Growth Rate (M USD)
Figure 81. South America Antiviral Drugs for Influenza Market Size by Country in 2024
Figure 82. Brazil Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antiviral Drugs for Influenza Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antiviral Drugs for Influenza Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antiviral Drugs for Influenza Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antiviral Drugs for Influenza Market Size by Region in 2024
Figure 92. Saudi Arabia Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antiviral Drugs for Influenza Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antiviral Drugs for Influenza Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antiviral Drugs for Influenza Production Market Share by Region (2020-2025)
Figure 103. North America Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antiviral Drugs for Influenza Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antiviral Drugs for Influenza Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Antiviral Drugs for Influenza Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Antiviral Drugs for Influenza Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Antiviral Drugs for Influenza Market Share Forecast by Type (2026-2035)
Figure 111. Global Antiviral Drugs for Influenza Sales Forecast by Application (2026-2035)
Figure 112. Global Antiviral Drugs for Influenza Market Share Forecast by Application (2026-2035)
